Spark Therapeutics, Inc. is a prominent gene therapy company focused on addressing orphan diseases through innovative treatments. The company develops a robust pipeline of product candidates aimed at treating rare blinding conditions, hematologic disorders, and neurodegenerative diseases. Their mission involves challenging the limitations of current therapeutic approaches and augmenting them with cutting-edge gene therapies.

Services include:
– Gene therapy development
– Regulatory affairs consulting
– Clinical trial management
– Data management and analysis
– Patient recruitment and retention strategies
– Biostatistics and statistical analysis
– Quality assurance and compliance support

Spark Therapeutics, Inc. is dedicated to advancing the field of gene therapy and improving patient outcomes. For further information, please visit sparktx.com.